Leap Therapeutics, Inc. (5MC.F)
Frankfurt - Frankfurt Delayed price. Currency in EUR
Add to watchlist
As of 08:10AM CEST. Market open.
| Previous close | 2.0600 |
| Open | 2.0600 |
| Bid | 2.1200 x N/A |
| Ask | 2.2600 x N/A |
| Day's range | 2.0600 - 2.0600 |
| 52-week range | 1.0300 - 6.8500 |
| Volume | |
| Avg. volume | 63 |
| Market cap | 78.825M |
| Beta (5Y monthly) | 0.54 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- GuruFocus.com
Leap Therapeutics Inc (LPTX) Q1 2024 Earnings: Financial Resilience Amidst Clinical Progress
Significant Reduction in Net Loss and Strategic Clinical Advancements
- Zacks
Here's Why Leap Therapeutics (LPTX) is Poised for a Turnaround After Losing -28.92% in 4 Weeks
Leap Therapeutics (LPTX) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.
© 2024 Yahoo. All rights reserved.